Pfizer announces positive top-line results from the ORAL Start Phase 3 study of Tofacitinib in RA
31 July 2012 | By Pfizer
Pfizer also provides update on Tofacitinib filing in the U.S.
List view / Grid view
News
Pluristem’s PLX Cells show efficacy in treating lung disease
31 July 2012 | By FINN PARTNERS
Statistically significant animal model results indicate PLX cells could improve the lives of people with interstitial lung disease...
FOSS NIRSystems introduces the NIRS DS2500 analyzer
31 July 2012 | By FOSS NIRSystems Inc
FOSS NIRSystems is pleased to announce the introduction of the FOSS NIRS™ DS2500 analyzer...
Lilly supports research to determine what a dog’s nose knows about people with diabetes and severe hypoglycemia
30 July 2012 | By Eli Lilly and Company
Data to explore future treatment possibilities for people with type 1 diabetes...
Afinitor® approved by European Commission to treat patients with the most common form of advanced breast cancer
30 July 2012 | By Novartis
The EC has approved Afinitor®...
Abbott’s HUMIRA® (adalimumab) approved in Europe for treatment of non-radiographic axial spondyloarthritis
30 July 2012 | By Abbott
The European Commission has approved HUMIRA®...
GSK announces acquisition of 79% of Human Genome Sciences shares
30 July 2012 | By GlaxoSmithKline
GSK announced the results of its initial tender offer for all outstanding shares of HGS...
Pooled analysis showed Onglyza® provided improvements in key measures of blood sugar control
30 July 2012 | By Bristol-Myers Squibb
Bristol-Myers Squibb and AstraZeneca announced the results of analyses...
Roche reports second positive study of RoACTEMRA given to patients with rheumatoid arthritis
27 July 2012 | By Roche
Data will be submitted to health authorities globally...
Once-daily dolutegravir is non-inferior to twice-daily raltegravir in treatment-naïve adults with HIV-1
27 July 2012 | By GlaxoSmithKline
Findings support progression towards registration...
pSivida announces ILUVIEN® marketing authorisation in Germany
27 July 2012 | By pSivida Corp.
For the treatment of vision impairment associated with chronic diabetic macular edema...
Luitpold Pharmaceuticals, Inc. receives complete response letter for Injectafer® from the U.S. FDA
26 July 2012 | By Daiichi Sankyo
Luitpold Pharmaceuticals submitted a New Drug Application to the U.S. FDA...
FDA clears Roche’s vitamin D laboratory test
26 July 2012 | By Roche
Fully automated assay for widely available platforms offers labs efficient solution to help assess patient vitamin D levels...
Results announcement for the second quarter 2012
25 July 2012 | By GlaxoSmithKline
GSK delivers Q2 core EPS of 26.4p and dividend of 17p...
Sanofi Pasteur’s dengue vaccine demonstrates proof of efficacy
25 July 2012 | By Sanofi Pasteur
Early data analysis confirms excellent safety profile...
